Evidence map›Paper›PMID 37663136›Full record

ArticleIDCases2023

Metagenomic next-generation sequencing for diagnosis and efficacy evaluation of a critical case of SFTS complicated by invasive pulmonary aspergillosis.

Xing Meng, Yan Liu, Jun Li, Liang Wang, Ruixue Shi, Ying Chen, Yun Zhu, Shifang Zhuang

Open access · goldAbstract readCase Reports
In one paragraph

Article in IDCases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xing MengDepartment of Emergency Intensive Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yan LiuGenskey Medical Technology Co., Ltd, Beijing, China.
Jun LiGenskey Medical Technology Co., Ltd, Beijing, China.
Liang WangGenskey Medical Technology Co., Ltd, Beijing, China.
Ruixue ShiGenskey Medical Technology Co., Ltd, Beijing, China.
Ying ChenGenskey Medical Technology Co., Ltd, Beijing, China.
Yun ZhuGenskey Medical Technology Co., Ltd, Beijing, China.
Shifang ZhuangGenskey Medical Technology Co., Ltd, Beijing, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by SFTS virus (SFTSV). SFTS patients were prone to invasive pulmonary aspergillosis (IPA), which was directly related to increased mortality. Here, we present a critical case of SFTS complicated by IPA in a previously healthy 58-year-old woman. On day 1, SFTSV and three different

Indexed as

Invasive pulmonary aspergillosisMetagenomic next-generation sequencingSevere fever with thrombocytopenia syndrome

Identifiers

PMID37663136
PMCPMC10470360
OpenAlexW4386052486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.